Four dominant e-cigarette producers face an inquiry into the health impacts of their products as the U.S. House Power and Commerce Panel asked on Wednesday in regards to the firms’ analysis and marketing practices.
The panel drafted letters to Juul Labs Inc, 35% owned by Marlboro producer Altria Group, Fontem Ventures, Japan Tobacco, and Reynolds American, an arm of British American Tobacco.
The letter to Juul asked if the corporate has conducted or financed research on the well-being implications of utilizing its products and the effectiveness of Juul in helping users quit smoking. It questioned if Juul has sent info to the Food and Drug Administration (FDA).
Kaelan Hollon, a spokesperson for Reynolds American, stated the corporate is examining the letter and believes “minors should never use tobacco merchandise as well as vapor products.”
Japan Tobacco mentioned in a statement it welcomes any opportunity to “set out the responsible approaches” it takes in its advertising and marketing.
The inquiry comes amid growing scrutiny of the e-cigarette business by administrators. A separate House panel in July revealed internal Juul emails that committee staff described as attempts to “enter schools and convey its messages straight to teenagers.”
Juul’s co-founder James Monsees explained the panel the corporate’s target market is adults who smoke.
Executive Frank Pallone, the Democratic chairperson of the panel, cited vaping-linked lung diseases recently reported by the Facilities for Disease Control and Prevention. He requested answers and paperwork by Sept. 20.
The CDC said on Wednesday it’s probing 153 possible cases of extreme lung illness related to e-cigarette use in 16 states.